These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20859195)

  • 21. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neck dissection for advanced lymph node metastasis before definitive radiotherapy for primary carcinoma of the head and neck.
    Smeele LE; Leemans CR; Reid CB; Tiwari R; Snow GB
    Laryngoscope; 2000 Jul; 110(7):1210-4. PubMed ID: 10892698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncologic effectiveness of selective neck dissection in the N0 irradiated neck.
    Solares CA; Fritz MA; Esclamado RM
    Head Neck; 2005 May; 27(5):415-20. PubMed ID: 15712298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V; Geiger M; Lotter M; Sauer R
    Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
    Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
    Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of treatment results for base of tongue cancer.
    Sessions DG; Lenox J; Spector GJ; Chao C; Chaudry OA
    Laryngoscope; 2003 Jul; 113(7):1252-61. PubMed ID: 12838028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
    J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users.
    Gillespie MB; Moody MW; Lee FS; Poole LJ; Hornig JD; Lathers D; Young MR; Day TA
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):28-31. PubMed ID: 17224518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.
    Perry DJ; Chan K; Wolden S; Zelefsky MJ; Chiu J; Cohen G; Zaider M; Kraus D; Shah J; Lee N
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1140-6. PubMed ID: 19560882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
    Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
    Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
    Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
    Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
    Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
    Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Previous head and neck cancers portend poor prognoses in lung cancer patients.
    Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
    Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
    Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined chemo-radiotherapy in non-operable cervico-facial neoplasms. Final results of an experience with non-selected patients].
    Pirtoli L; Bellezza A; Tucci E; Pepi F; Crastolla AM; Farzad M; Bindi M; Sebaste L
    Radiol Med; 1995; 90(1-2):94-101. PubMed ID: 7569105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.